Medical Devices Therapeutics Lithium-Driven Neural Inhibition Devices For Chronic Pain And Local Anesthesia Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Desired Partnership: Co-development, Licensing IP: Patent Pending
Research Tools Therapeutics Rapid Selection Of High-Value Internalizing Binders For Targeted Therapeutics Lentiviral display platform engineered to directly select and enrich antibodies based on their ability to induce receptor-mediated endocytosis, thereby streamlining the discovery of highly… Interests: Antibody, Antibody Desired Partnership: Co-development, Licensing IP: Patent Pending
Research Tools Therapeutics A Programmable Translational Activator Platform For Restoring Endogenous Protein Expression In Haploinsufficiency Disorders The CIRTS-4GT3 platform is a compact, programmable system that uses guide RNAs and human protein domains to boost production of specific proteins in cells,… Interests: Gene Therapy Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Oral Systemically-Bioavailable Butyrate For Treating Inflammatory Diseases Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Interests: Allergy, Autoimmune, Chemical Synthesis, Gastrointestinal, Inflammatory, Microbiome Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Antibody-Polymer Conjugates For Engaging T Cells To Destroy Cancer Cells An antibody linked to a polymer that connects T cells to cancer cells enabling broad cancer targeting and effective tumor cell killing without needing… Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Therapeutics Amphiregulin Screening And Inhibition Methods For Reducing Metastasis And Enhancing Radiotherapy Efficacy Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Interests: Biomarker, Oncology Desired Partnership: Co-development, Licensing IP: Patent Pending
Research Tools Therapeutics Nucleic Acid Enrichment And Sequencing Method For Detecting Off-Target Base Editing Events Inrich-seq is a new method that selectively enriches and sequences inosine-containing DNA or RNA, enabling highly sensitive, genome-wide detection of off-target effects from adenine… Interests: Drug Screening, Gene Therapy Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Therapeutics A Biomarker Analysis Platform For Predicting Immunotherapy Response And Survival In Cancer Patients Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Interests: Biomarker, Immunotherapy, Oncology Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Mesenchymal Stem Cell And Exosome-Based Therapeutics For Restoring Ovarian Function In Premature Ovarian Insufficiency Therapeutic strategy using human mesenchymal stem cells or their exosomes to restore ovarian function and fertility in premature ovarian insufficiency by promoting cell growth,… Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Nanoparticles Containing Multiple Cleavable Prodrugs For Cancer Therapy Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Interests: Chemical Synthesis, Combination Therapy, Drug Delivery Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Small Molecule Therapeutics For Inhibiting Carotid Body Hypersensitivity To Treat Sleep-Related Breathing Disorders New compounds that inhibit an enzyme to reduce hydrogen sulfide in the carotid body, helping to normalize breathing and prevent sleep apnea by targeting… Interests: Small Molecules Desired Partnership: Co-development, Licensing IP: Patent Issued
Therapeutics Lymphangiogenesis For Therapeutic Immunomodulation A vaccine platform that uses engineered lymphangiogenesis factors and antigens to stimulate lymphatic endothelial cells, creating strong, long-lasting immune memory or tolerance with fewer… Interests: Biologics, Immunotherapy, Oncology Desired Partnership: Co-development, Licensing IP: Patent Pending
